Nitric oxide and sphingolipids: Mechanisms of interaction and role in cellular pathophysiology

Biological Chemistry

Volumn 389, Issue 11, 2008, Pages 1391-1397

  Perrotta, Cristiana ^a   De Palma, Clara ^a   Clementi, Emilio ^b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; Ceramide; Cyclic GMP; Inflammation; Nitric oxide; Sphingomyelinases; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INTERACTION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELLS; CYCLIC GMP; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 56549103857     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.155     Document Type: Review

References (74)

1. Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J., and Kronke, M. (1996). FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86, 937-947.
2. Alderton, W.K., Cooper, C.E., and Knowles, R.G. (2001). Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615.
3. Alvarez, S.E., Milstien, S., and Spiegel, S. (2007). Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol. Metab. 18, 300-307.
4. Augé, N., Nègre-Salvayre, A., Salvayre, R., and Levade, T. (2000). Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog. Lipid Res. 39, 207-229.
5. Barsacchi, R., Perrotta, C., Sestili, P., Cantoni, O., Moncada, S., and Clementi, E. (2002). Cyclic GMP-dependent inhibition of acid sphingomyelinase by nitric oxide: an early step in protection against apoptosis. Cell Death Diff. 9, 1248-1255.
6. Barsacchi, R., Perrotta, C., Bulotta, S., Moncada, S., Borgese, N., and Clementi, E. (2003). Activation of endothelial nitric oxide synthase by tumor necrosis factor-α: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-39 kinase and Akt. Mol. Pharmacol. 63, 886-895.
7. Baud, V. and Karin, M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377.
8. Belka, C., Wiegmann, K., Adam, D., Holland, R., Neuloh, M., Herrmann, F., Krönke, M., and Brach, M.A. (1995). Tumor necrosis factor (TNF)-α activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J. 14, 1156-1165.
9. Bhatia, R., Matsushita, K., Yamakuchi, M., Morrell, C.N., Cao, W., and Lowenstein, C.J. (2004). Ceramide triggers Weibel-Palade body exocytosis. Circ. Res. 95, 319-324.
10. Bogdan, C. (2001). Nitric oxide and the immune response. Nat. Immunol. 2, 907-916.
11. Borges, R., Machado, J.D., Betancor, G., and Camacho, M. (2002). Pharmacological regulation of the late steps of exocytosis. Ann. NY Acad. Sci. 971, 284-286.
12. Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.W., Craven, S.E., Santillano, D.R., Wu, Z., Huang, F., Xia, H., Peters, M.F., et al. (1996). Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α-1-syntrophin mediated by PDZ domains. Cell 84, 757-767.
13. Brune, B. (2003). Nitric oxide: NO apoptosis or turning it ON? Cell Death Diff. 10, 864-869.
14. Bulotta, S., Barsacchi, R., Rotiroti, D., Borgese, N., and Clementi, E. (2001). Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-α: a novel feedback mechanism regulating cell death. J. Biol. Chem. 276, 6659-6536.
15. Canossa, M., Giordano, E., Cappello, S., Guarnieri, C., and Ferri, S. (2002). Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 99, 3282-3287.
16. Castillo, S.S., Levy, M., Wang, C., Thaikoottathil, J.V., Khan, E., and Goldkorn, T. (2007). Nitric oxide-enhanced caspase-3 and acidic sphingomyelinase interaction: a novel mechanism by which airway epithelial cells escape ceramide-induced apoptosis. Exp. Cell Res. 313, 816-823.
17. De Nadai, C., Sestili, P., Cantoni, O., Lievremont, J.P., Sciorati, C., Barsacchi, R., Moncada, S., Meldolesi, J., and Clementi, E. (2000). Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide. Proc. Natl. Acad. Sci. USA 97, 5480-5485.
18. De Palma, C., Meacci, E., Perrotta, C., Bruni, P., and Clementi, E. (2006). Endothelial nitric oxide synthase activation by tumor necrosis factor α through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler. Thromb. Vasc. Biol. 26, 99-105.
19. De Palma, C., Falcone, S., Panzeri, C., Radice, S., Bassi, M.T., and Clementi, E. (2008). Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection. J. Neurochem. 106, 193-204.
20. Domek-Lopacinska, K. and Strosznajder, J.B. (2005). Cyclic GMP metabolism and its role in brain physiology. J. Physiol. Pharmacol. 56, 15-34.
21. Duckett, C.S. (2002). Apoptosis and NF-κB: the FADD connection. J. Clin. Invest. 109, 579-580.
22. Falcone, S., Perrotta, C., De Palma, C., Pisconti, A., Sciorati, C., Capobianco, A., Rovere-Querini, P., Manfredi, A.A., and Clementi, E. (2004). Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells. J. Immunol. 173, 4452-4463.
23. Felley-Bosco, E., Bender, F.C., Courjault-Gautier, F., Bron, C., and Quest, A.F. (2000). Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA 97, 14334-14339.
24. Florio, T., Arena, S., Pattarozzi, A., Thellung, S., Corsaro, A., Villa, V., Massa, A., Diana, F., Spoto, G., Forcella, S., et al. (2003). Basic fibroblast growth factor activates endothelial nitric oxide synthase in CHO-CK1 cells via the activation of ceramide synthesis. Mol. Pharmacol. 63, 297-310.
25. Fulton, D., Gratton, J.P., and Sessa, W.C. (2001). Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 299, 818-824.
26. Futerman, A.H. (2006). Intracellular trafficking of sphingolipids: relationship to biosynthesis. Biochim. Biophys. Acta 1758, 1885-1892.
27. Garcìa-Cardeña, G., Oh, P., Liu, J., Schnitzer, J.E., and Sessa, W.C. (1996). Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signalling. Proc. Natl. Acad. Sci. USA 93, 6448-6453.
28. Grassmé, H., Riethmüller, J., and Gulbins, E. (2007). Biological aspects of ceramide-enriched membrane domains. Prog. Lipid Res. 46, 161-170.
29. Gulbins, E. (2003). Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol. Res. 47, 393-399.
30. Hannun, Y.A. and Obeid, L.M. (2008). Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell. Biol. 9, 139-150.
31. Hildt, E. and Oess, S. (1999). Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I. J. Exp. Med. 189, 1707-1714.
32. Hinkovska-Galcheva, V., Boxer, L.A., Kindzelskii, A., Hiraoka, M., Abe, A., Goparju, S., Spiegel, S., Petty, H.R., and Shayman, J.A. (2005). Ceramide 1-phosphate, a mediator of phagocytosis. J. Biol. Chem. 280, 26612-26621.
33. Huwiler, A., Pfeilschifter, J., and van den Bosch, H. (1999). Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J. Biol. Chem. 274, 7190-7195.
34. Huwiler, A., Kolter, T., Pfeilschifter, J., and Sandhoff, K. (2000). Physiology and pathophysiology of sphingolipid metabolism and signalling. Biochim. Biophys. Acta 1485, 63-99.
35. Igarashi, J. and Michel, T. (2000). Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. J. Biol. Chem. 275, 32363-32370.
36. Igarashi, J., Bernier, S.G., and Michel, T. (2001). Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. J. Biol. Chem. 276, 12420-12426.
37. Kester, M. and Kolesnick, R. (2003). Sphingolipids as therapeutics. Pharmacol. Res. 47, 365-371.
38. Kim, Y.M., Chung, H.T., Kim, S.S., Han, J.A., Yoo, Y.M., Kim, K.M., Lee, G.H., Yun, H.Y., Green, A., Li, J., et al. (1999). Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J. Neurosci. 19, 6740-6747.
39. Ko, Y.G., Lee, J.S., Kang, Y.S., Ahn, J.H., and Seo, J.S. (1999). TNF-α-mediated apoptosis is initiated in caveolae-like domains. J. Immunol. 162, 7217-7223.
40. Kone, B.C., Kuncewicz, T., Zhang, W., and Yu, Z.Y. (2003). Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am. J. Physiol. Renal Physiol. 285, F178-190.
41. Kuhlencordt, P.J., Gyurko, R., Han, F., Scherrer-Crosbie, M., Aretz, T.H., Hajjar, R., Picard, M.H., and Huang, P.L. (2001). Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448-454.
42. Kwon, Y.-G., Min, J.K., Kim, K.M., Lee, D.J., Billiar, T.R., and Kim, Y.M. (2001). Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 276, 10627-10633.
43. Lacour, S., Hammann, A., Grazide, S., Lagadic-Gossmann, D., Athias, A., Sergent, O., Laurent, G., Gambert, P., Solary, E., and Dimanche-Boitrel, M.T. (2004). Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 64, 3593-3598.
44. Lang, T. (2007). SNARE proteins and 'membrane rafts'. J. Physiol. 585, 693-698.
45. Lavieu, G., Scarlatti, F., Sala, G., Carpentier, S., Levade, T., Ghidoni, R., Botti, J., and Codogno, P. (2006). Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J. Biol. Chem. 281, 8518-8527.
46. Lawler, J.F. Jr., Yin, M., Diehl, A.M., Roberts, E., and Chatterjee, S. (1998). Tumor necrosis factor-α stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J. Biol. Chem. 273, 5053-5059.
47. Lazzarato, L., Donnola, M., Rolando, B., Marini, E., Cena, C., Coruzzi, G., Guaita, E., Morini, G., Fruttero, R., Gasco, A., et al. (2008). Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid. J. Med. Chem. 51, 1894-1903.
48. Liu, L. and Stamler, J.S. (1999). NO: an inhibitor of cell death. Cell Death Diff. 6, 937-942.
49. Madhusoodanan, K.S. and Murad, F. (2007). NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem. Res. 32, 681-694.
50. Melendez, A.J. (2008). Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets. Biochim. Biophys. Acta 1784, 66-75.
51. Moncada, S., Palmer, R.M., and Higgs, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
52. i protein/phosphoinositide 3-kinase pathway in endothelial cells. J. Biol. Chem. 276, 19672-19677.
53. Nagano, S., Takeda, M., Ma, L., and Soliven, B. (2001). Cytokine-induced cell death in immortalized Schwann cells: roles of nitric oxide and cyclic AMP. J. Neurochem. 77, 1486-1495.
54. Nisoli, E., Clementi, E., Carruba, M.O., and Moncada, S. (2007). Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ. Res. 100, 795-806.
55. Paolucci, C., Rovere, P., De Nadai, C., Manfredi, A.A., and Clementi, E. (2000). Nitric oxide inhibits the tumor necrosis factor-α-regulated endocytosis of human dendritic cells in a cyclic GMP-dependent way. J. Biol. Chem. 275, 19638-19644.
56. Park, S.J., Kim, Y.Y., Ju, J.W., Han, B.G., Park, S.I., and Park, B.J. (2001). Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. Biochem. Biophys. Res. Commun. 289, 1205-1210.
57. Perrotta, C., Bizzozero, L., Falcone, S., Rovere-Querini, P., Prinetti, A., Schuchman, E.H., Sonnino, S., Manfredi, A.A., and Clementi, E. (2007). Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. Cancer Res. 67, 7559-7564.
58. Pilane, C.M. and LaBelle, E.F. (2004). NO induced apoptosis of vascular smooth muscle cells accompanied by ceramide increase. J. Cell. Physiol. 199, 310-315.
59. Pilane, C.M. and LaBelle, E.F. (2005). Nitric oxide stimulated vascular smooth muscle cells undergo apoptosis induced in part by arachidonic acid derived eicosanoids. J. Cell. Physiol. 204, 423-427.
60. Prinetti, A., Chigorno, V., Mauri, L., Loberto, N., and Sonnino, S. (2007). Modulation of cell functions by glycosphingolipid metabolic remodeling in the plasma membrane. J. Neurochem. 103, 113-125.
61. Rikitake, Y., Hirata, K., Kawashima, S., Ozaki, M., Takahashi, T., Ogawa, W., Inoue, N., and Yokoyama, M. (2002). Involvement of endothelial nitric oxide in sphingosine-1 phosphate-induced angiogenesis. Arterioscl. Thromb. Vasc. Biol. 22, 108-114.
62. Sciorati, C., Rovere, P., Ferrarini, M., Heltai, S., Manfredi, A.A., and Clementi, E. (1997). Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes. J. Biol. Chem. 272, 23211-23215.
63. Sciorati, C., Rovere, P., Ferrarini, M., Paolucci, C., Heltai, S., Vaiani, R., Clementi, E., and Manfredi, A.A. (1999). Generation of nitric oxide by the inducible nitric oxide synthase protects γδ T cells from Mycobacterium tuberculosis-induced apoptosis. J. Immunol. 163, 1570-1576.
64. Segui, B., Andrieu-Abadie, N., Adam-Klages, S., Meilhac, O., Kreder, D., Garcia, V., Bruno, A.P., Jaffrezou, J.P., Salvayre, R., Kronke, M., and Levade, T. (1999). CD40 signals apoptosis through FAN-regulated activation of the sphingomyelinceramide pathway. J. Biol. Chem. 274, 37251-37258.
65. Takeda, Y., Tashima, M., Takahashi, A., Uchiyama, T., and Okazaki, T. (1999). Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. J. Biol. Chem. 274, 10654-10660.
66. Takuma, K., Phuagphong, P., Lee, E., Mori, K., Baba, A., and Matsuda, T. (2001). Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J. Biol. Chem. 276, 48093-48099.
67. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., and Simons, M. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247.
68. Viani, P., Giussani, P., Brioschi, L., Bassi, R., Anelli, V., Tettamanti, G., and Riboni, L. (2001). Ceramide in nitric oxide inhibition of glioma cell growth. Evidence for the involvement of ceramide traffic. J. Biol. Chem. 278, 9592-9601.
69. Wymann, M.P. and Schneiter, R. (2008). Lipid signalling in disease. Nat. Rev. Mol. Cell. Biol. 9, 162-176.
70. Yago, M.D., Tapia, J.A., Salido, G.M., Adeghate, E., Juma, L.M., Martinez-Victoria, E., Mañas, M., and Singh, J. (2002). Effect of sodium nitroprusside and 8-bromo cyclic GMP on nerve-mediated and acetylcholine-evoked secretory responses in the rat pancreas. Br. J. Pharmacol. 136, 49-56.
71. Ying, L. and Hofseth, L.J. (2007). An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 67, 1407-1410.
72. Zaccolo, M. and Movsesian, M.A. (2007). cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ. Res. 100, 1569-1578.
73. Zech, B., Köhl, R., von Knethen, A., and Brüne, B. (2003). Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases. Biochem. J. 371, 1055-1064.
74. Zeidan, Y.H. and Hannun, Y.A. (2007). Translational aspects of sphingolipid metabolism. Trends Mol. Med. 13, 327-336.